ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -56.16% | -55.54% | -39.78% | -35.03% | -27.51% |
| Total Depreciation and Amortization | 113.73% | 59.40% | 48.61% | 12.35% | 0.05% |
| Total Amortization of Deferred Charges | 1,846.67% | 1,876.74% | 1,347.22% | 256.86% | -9.09% |
| Total Other Non-Cash Items | 7.43% | 18.86% | 30.55% | 37.79% | 33.74% |
| Change in Net Operating Assets | -1,454.89% | -1,449.72% | -2,914.03% | -801.50% | -190.85% |
| Cash from Operations | -145.83% | -170.31% | -127.97% | -167.32% | -47.45% |
| Capital Expenditure | -41.98% | -101.64% | -114.85% | -89.82% | -2,130.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 112.50% | 105.46% | 133.41% | 323.64% | -268.00% |
| Total Debt Issued | -32.18% | -32.18% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 528.90% | -60.60% | 847.91% | -76.23% | -77.56% |
| Repurchase of Common Stock | -25.39% | -21.15% | -61.22% | -337.74% | -362.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | 33.08% | -9.09% | 542.69% | 710.78% | 386.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.25% | -228.81% | 205.06% | 985.01% | 707.73% |